Tele-dermatology Non-presential (TeleDermaSA)

Primary Care Clinical Trial

— TeleDermaSA  

Official title:

Evaluation of the Implementation of Tele-dermatology, in Its Modality of Non-presential Inter-consultation, in the Province of Salamanca.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05625295
• Other study ID #: 116
• Status: Completed
• Start date: November 1, 2022
• Est. completion date: July 1, 2023

Study information

• Verified date: July 2023
• Source: Fundacion para la Investigacion y Formacion en Ciencias de la Salud
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of the study is to evaluate the implementation of the Non-Face-to-Face Interconsultation of dermatology since it began to be used in August 2020 until August 2022 in the province of Salamanca (Spain)

Description:

Design: cross-sectional descriptive study. Subjects: The unit of analysis will be the NPIs performed in dermatology since its implementation in August 2020 until the present time in the health area of Salamanca. To analyze the face-to-face consultations to analyze the differences. A random sample of 500 PNCIs and 500 face-to-face consultations will be extracted.

Measurements: To analyze the ICNP and face-to-face IC to dermatology registered in the computerized clinical history made in PC from Medora and registered in Jimena. To record the number of consultations, type of pathology referred, dermatology response time, discharges after assessment, face-to-face consultations required, delay time, treatment required, follow-up required or not, diagnostic coincidence, quality of the photographic image sent.

A differentiated analysis will be made according to the use or not of the dermatoscope, type of center (urban, semi-urban and rural), gender of the patients and age groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: July 1, 2023
• Est. primary completion date: June 1, 2023
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• The unit of analysis will be the PNCIs performed in dermatology from Primary Care, registered in Medora software, with its corresponding photographic file, and its response in Jimena software of the dermatology service, from June 2021 to June 2022, one year.

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Primary Care
• Teledermatology

Intervention

Other:
• data collection protocol in clinical history
collection of data from the clinical history according to the established protocol

Locations

Country	Name	City	State
Spain	Centro de Salud La Alamedilla	Salamanca

Sponsors (1)

Lead Sponsor	Collaborator
Fundacion para la Investigacion y Formacion en Ciencias de la Salud

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Derivation rates per 10,000 h.	number of patients referred to the dermatology office	1 year